Note: Orbit Genomics's revenues are gauged from an analysis of company filings.
Orbit Genomics's Income Statement (based on Industry Averages)
Orbit Genomics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Orbit Genomics is developing and marketing.
Orbit Genomics doesn't have any recent trademark applications, indicating Orbit Genomics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ORBISEQ Computer software for medical testing and diagnostics for the early detection and risk assessment of Cancer, Companion Diagnostics, Cardiac Disease, Autism, Alzheimer's, Longevity and Aging, and Wellness
02/05/2018
ORBIT GENOMICS Scientific research in the field of oncology and human genealogy
12/15/2017
See all trademarks and details in the Full Report.
Market Share of Orbit Genomics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Orbit Genomics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Orbit Genomics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Orbit Genomics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.